USPTO 2015–2025 USPTO PatentsView US Corporation

Ultima Genomics, Inc.

USPTO PatentsView assignee record - 53 granted patents across 15 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ultima ranks #6,398 of 49,997 tracked US assignees by granted-patent volume, with 53 patents across 15 technology areas.

#6,398
of 49,997 US assignees by volume
Top 3%
by Innovation Score (61.1/100)
22.8
avg claims per patent
+925%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6398 · US Corporation #6,398 · 53 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-STRONG · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 53 grants
  • UPPER-Q #6,398/49,997
  • PHOTO-FINISH The Research…
  • CPC-FOCUS C12Q · 15 areas
  • INNOV-STRONG 61.1/100
  • CLAIMS-DENSE 22.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +925% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: The Research Foundation of the State University of New York (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ultima’s 61.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ultima

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ultima's Innovation Score is 61.1/100 (top 3% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ultima?

Each dot is one of Ultima’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ultima’s own 22.8 claims/patent is ABOVE the 14.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ultima vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 52.953.053.05353.053.053.1 0510152025 Granted patents (volume) Avg claims / patent The Research Foundation of the State University of New York - 53, 16.45The Research Foun…Totani Corporation - 53, 5.58TotaniUIH America, Inc. - 53, 19.08UIH AmericaUltrahaptics IP Ltd - 53, 16.55Ultrahaptics IPUniversity of Limerick - 53, 14.36University of Lim…Unwired Planet, LLC - 53, 19.28Unwired PlanetVeoneer Sweden AB - 53, 13.13Veoneer Sweden ABVarcode Ltd. - 53, 10.02VarcodeUltima Genomics, Inc. - 53, 22.77Ultima Genomics
Ultima vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ultima's grants concentrate

Ultima Genomics, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 83% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2022 (14 grants) versus a trough of 2 in 2020. By volume, Ultima sits between The Research Foundation of the State University of New York and Varcode Ltd..

Ultima's three-year grant acceleration

Ultima Genomics, Inc. shows 35 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ultima's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ultima holds 53 patents at rank #6,397, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ultima

By rank, the assignees closest to #6,397 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Ultima's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ultima, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Ultima ranks #108 of 2,502 assignees by patent count in that subclass.

Ultima's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

61 Top 3% higher than 97% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 2019202020212022202320242025 8
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Ultima Genomics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 4 7.5%
2020 2 3.8%
2021 4 7.5%
2022 14 26.4%
2023 11 20.8%
2024 10 18.9%
2025partial year 8 15.1%

Which technologies does Ultima Genomics, Inc. patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Ultima Genomics, Inc.'s patent record in context - here's where to go next.

  • Ultima Genomics, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 83% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #6,398 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ultima Genomics, Inc. against The Research Foundation of the State University of New York, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 61.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.